Lung function and exacerbations in patients with COPD escalated to triple therapy: The RETRIEVE real-world study

被引：0
|
作者：
Tryfon, Stavros [1 ]
Papadopoulou, Efthymia [1 ]
Bertoli, Maria [2 ]
Exarchos, Konstantinos [3 ]
Ginis, Alexandros [2 ]
Kostikas, Konstantinos [3 ]
机构：
[1] Gen Hosp Thessaloniki G Papanikolaou, Pulmonol Dept, Thessaloniki, Greece
[2] ELPEN Pharmaceut Co Inc, Med Dept, Pikermi, Greece
[3] Univ Ioannina, Sch Med, Resp Med Dept, Ioannina, Greece
来源：
RESPIROLOGY | 2023年 / 28卷 / 12期
关键词：
chronic obstructive pulmonary disease; COPD exacerbations; FEV1; open triple therapy; salmeterol-fluticasone fixed-dose combination;
D O I：
10.1111/resp.14612
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：1166 / 1169
页数：4
相关论文
共 50 条
  • [21] Risk of future exacerbations among COPD patients - a real-world register-based cohort study in Germany
    Vogelmeier, C. F.
    Diesing, J.
    Kossack, N.
    Pignot, M.
    Friedrich, F.
    PNEUMOLOGIE, 2021, 75 : S12 - S12
  • [22] Risk of future exacerbations among COPD patients - a real-world register-based cohort study (AvoidEx)
    Vogelmeier, Claus
    Pignot, Marc
    Wiklund, Fredrik
    Nuevo, Javier
    Telg, Gunilla
    Janson, Christer
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [23] Triple Inhaler versus Dual Bronchodilator Therapy in COPD: Real-World Effectiveness on Mortality
    Suissa, Samy
    Dell'Aniello, Sophie
    Ernst, Pierre
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2022, 19 (01) : 1 - 9
  • [24] Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study [Corrigendum]
    Strange, C.
    Tkacz, J.
    Schinkel, J.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2024, 19 : 1799 - 1799
  • [25] Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population
    Vestbo, Jorgen
    Vogelmeier, Claus F.
    Small, Mark
    Siddall, James
    Fogel, Robert
    Kostikas, Konstantinos
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2019, 14 : 853 - 861
  • [26] Predictors of Comparative Real-World Effectiveness of Triple Therapy Versus Dual Bronchodilation in Frequently Exacerbating Patients with COPD
    Kerkhof, M.
    Voorham, J.
    Georges, G.
    Vezzoli, S.
    Papi, A.
    Vogelmeier, C.
    Singh, D.
    Fabbri, L. M.
    Kocks, J. W. H.
    Price, D. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [27] Improvement in COPD-specific Symptoms and Lung Function when treated with extra fine fixed Triple Therapy - real-world Data from TriOptimize
    Trinkmann, F.
    Javan, Bahari S.
    Criee, P. C.
    Hoevelmann, R.
    Bogoevska, V
    Gessner, C.
    PNEUMOLOGIE, 2022, 76 : S53 - S53
  • [28] Impact of Lung Function and Exacerbations on Health-Related Quality of Life in COPD Patients Within One Year: Real-World Analysis Based on Claims Data
    Stoeber, Alisa
    Lutter, Johanna, I
    Schwarzkopf, Larissa
    Kirsch, Florian
    Schramm, Anja
    Vogelmeier, Claus F.
    Leidl, Reiner
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2021, 16 : 2637 - 2651
  • [29] TRICOP - A real-world effectiveness study with a single-inhaler extrafine triple therapy over 52 weeks in Austrian patients with COPD
    Marth, Katharina
    Renner, Andreas
    Pohl, Wolfgang
    WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 (19-20) : 616 - 616
  • [30] TRICOP - A Real-world effectiveness study with a single-inhaler extrafine triple therapy over 52 weeks in Austrian patients with COPD
    Marth, Katharina
    Renner, Andreas
    Pohl, Wolfgang
    RESPIRATORY MEDICINE, 2021, 182
12345